Evidence map›Paper›PMID 40651942›Full record

ArticleNature communications2025

Androgen receptor promotes arachidonic acid metabolism and angiogenic microenvironment in AFP-negative hepatocellular carcinoma.

Zhilong Lin, Xiaofei Liu, Houwei Wang, Shumin Li, Ziqiang Miao, Jing Yang, Yuting Zhang, Kai Lei, Yifan Wu, Youmei Kang and 12 more

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Zhilong Lin *Center of Hepato-Pancreato-Biliary Surgery, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.ORCID http://orcid.org/0009-0002-9425-3609
Xiaofei Liu *Department of Gastroenterology and Hepatology, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Houwei Wang *Center of Hepato-Pancreato-Biliary Surgery, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Shumin Li *Department of Oncology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Ziqiang Miao *Organ Transplant Center, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Jing YangDepartment of Gastroenterology and Hepatology, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Yuting ZhangDepartment of Pathology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Kai LeiCenter of Hepato-Pancreato-Biliary Surgery, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Yifan WuDepartment of Gastroenterology and Hepatology, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Youmei KangInstitute of Precision Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Ruoyin ZhengCenter of Hepato-Pancreato-Biliary Surgery, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Zonglin XieDepartment of Oncology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Yixi WenInstitute of Precision Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Xiaoxue RenDepartment of Oncology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Chunxiao LiuInstitute of Precision Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.ORCID http://orcid.org/0000-0002-8677-1943
Alfred Sze-Lok ChengSchool of Biomedical Sciences, The Chinese University of Hong Kong, Hong Kong, China.
Yubin XieInstitute of Precision Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.ORCID http://orcid.org/0000-0002-3566-4849
Shuling ChenInstitute of Precision Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Ming KuangCenter of Hepato-Pancreato-Biliary Surgery, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.ORCID http://orcid.org/0000-0002-7397-5779
Sui PengDepartment of Gastroenterology and Hepatology, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China. pengsui@mail.sysu.edu.cn.ORCID http://orcid.org/0000-0002-7399-2579
Zhenwei PengClinical Trials Unit, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China. pzhenw@mail.sysu.edu.cn.ORCID http://orcid.org/0000-0002-0617-3805
Zihao DaiCenter of Hepato-Pancreato-Biliary Surgery, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China. daizihao@mail2.sysu.edu.cn.ORCID http://orcid.org/0000-0002-8921-2389

Funding

National Natural Science Foundation of China (National Science Foundation of China) 82172047National Natural Science Foundation of China (National Science Foundation of China) 82373004
6 · The paper itself

Abstract

Alpha-fetoprotein (AFP) is a classic biomarker for hepatocellular carcinoma (HCC). AFP-positive HCC (AFP

Indexed as

alpha-FetoproteinsArachidonic AcidCarcinoma, HepatocellularLiver NeoplasmsNeovascularization, PathologicReceptors, AndrogenAndrogen Receptor AntagonistsAnilidesAnimalsCell Line, TumorErbB ReceptorsFemaleGene Expression Regulation, NeoplasticHumansMaleMiceAFP protein, humanalpha-FetoproteinsAndrogen Receptor AntagonistsAnilidesArachidonic AcidAR protein, humanbicalutamideEGFR protein, humanErbB ReceptorsNitrilesPhenylurea CompoundsQuinolinesReceptors, AndrogenTosyl Compounds

Identifiers

PMID40651942
PMCPMC12255818

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.